These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21918192)

  • 21. Successful immunotherapy of an intraocular tumor in mice.
    Schurmans LR; den Boer AT; Diehl L; van der Voort EI; Kast WM; Melief CJ; Toes RE; Jager MJ
    Cancer Res; 1999 Oct; 59(20):5250-4. PubMed ID: 10537305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.
    Zhang J; Zhou Z; Wang C; Shen J; Zheng Y; Zhang L; Wang J; Xia D
    Cancer Immunol Immunother; 2011 Apr; 60(4):559-73. PubMed ID: 21240488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
    Chen PW; Ksander BR
    Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis.
    Schurmans LR; Diehl L; den Boer AT; Sutmuller RP; Boonman ZF; Medema JP; van der Voort EI; Laman J; Melief CJ; Jager MJ; Toes RE
    J Immunol; 2001 Nov; 167(10):5832-7. PubMed ID: 11698457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of TNFR p55 results in heightened expression of IFN-γ and IL-17 during the development of reactive arthritis.
    Eliçabe RJ; Cargnelutti E; Serer MI; Stege PW; Valdez SR; Toscano MA; Rabinovich GA; Di Genaro MS
    J Immunol; 2010 Oct; 185(7):4485-95. PubMed ID: 20810989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.
    Wang B; Fujisawa H; Zhuang L; Freed I; Howell BG; Shahid S; Shivji GM; Mak TW; Sauder DN
    J Immunol; 2000 Dec; 165(12):6783-90. PubMed ID: 11120799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells.
    Cornelissen F; Mus AM; Asmawidjaja PS; van Hamburg JP; Tocker J; Lubberts E
    Arthritis Res Ther; 2009; 11(6):R194. PubMed ID: 20017902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
    Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
    Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent and synergistic effects of interleukin-18 and interleukin-12 in augmenting cytotoxic T lymphocyte responses and IFN-gamma production in aging.
    Zhang Y; Wang Y; Gilmore X; Xu K; Mbawuike IN
    J Interferon Cytokine Res; 2001 Oct; 21(10):843-50. PubMed ID: 11710997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell-mediated tumor rejection displays diverse dependence upon perforin and IFN-gamma mechanisms that cannot be predicted from in vitro T cell characteristics.
    Peng L; Krauss JC; Plautz GE; Mukai S; Shu S; Cohen PA
    J Immunol; 2000 Dec; 165(12):7116-24. PubMed ID: 11120842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection.
    Ligocki AJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):813-23. PubMed ID: 26934137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
    Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effector component of the cytotoxic T-lymphocyte response has a biphasic pattern after burn injury.
    Hunt JP; Hunter CT; Brownstein MR; Giannopoulos A; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
    J Surg Res; 1998 Dec; 80(2):243-51. PubMed ID: 9878320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses.
    Liu Y; Bi X; Xu S; Xiang J
    Cancer Res; 2005 Jun; 65(11):4955-62. PubMed ID: 15930318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
    Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
    Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFN-gamma decreases CTL generation by limiting IL-2 production: A feedback loop controlling effector cell production.
    Hidalgo LG; Urmson J; Halloran PF
    Am J Transplant; 2005 Apr; 5(4 Pt 1):651-61. PubMed ID: 15760388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.